The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications
Schizophrenia is a debilitating psychiatric disorder, leading to both physical and social morbidity. Despite its importance, the etiology of schizophrenia remains poorly understood. Furthermore, its mainstream treatments fail to address all aspects of the disorder and are associated with significant...
Main Authors: | Tomasz Szeligowski, Alexandra Lim Yun, Belinda R. Lennox, Philip W. J. Burnet |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2020.00156/full |
Similar Items
-
The Role of Cytokines in the Pathogenesis of Schizophrenia
by: Bartosz Dawidowski, et al.
Published: (2021-08-01) -
Women with Schizophrenia over the Life Span: Health Promotion, Treatment and Outcomes
by: Alexandre González-Rodríguez, et al.
Published: (2020-08-01) -
How do participants in clinical trials compare with other patients with schizophrenia?
by: Robert Freudenthal, et al.
Published: (2021-06-01) -
Physical activity in schizophrenia is higher in the first episode than in subsequent ones
by: Sebastian eWalther, et al.
Published: (2015-01-01) -
Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention
by: Felipe V. Gomes, et al.
Published: (2021-04-01)